Showing 201 - 220 results of 3,733 for search '"Stem cell', query time: 0.10s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204
  5. 205

    Oral Complications in Hematopoietic Stem Cell Recipients: The Role of Inflammation by T. M. Haverman, J. E. Raber-Durlacher, W. M. H. Rademacher, S. Vokurka, J. B. Epstein, C. Huisman, M. D. Hazenberg, J. J. de Soet, J. de Lange, F. R. Rozema

    Published 2014-01-01
    “…Hematopoietic stem cell transplantation (HSCT) is widely used as a potentially curative treatment for patients with various hematological malignancies, bone marrow failure syndromes, and congenital immune deficiencies. …”
    Get full text
    Article
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210

    Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells by Francesco Orio, Giovanna Muscogiuri, Stefano Palomba, Bianca Serio, Mariarosaria Sessa, Valentina Giudice, Idalucia Ferrara, Libuse Tauchmanovà, Annamaria Colao, Carmine Selleri

    Published 2014-01-01
    “…Early and late endocrine disorders are among the most common complications in survivors after hematopoietic allogeneic- (allo-) and autologous- (auto-) stem cell transplant (HSCT). This review summarizes main endocrine disorders reported in literature and observed in our center as consequence of auto- and allo-HSCT and outlines current options for their management. …”
    Get full text
    Article
  11. 211
  12. 212
  13. 213
  14. 214
  15. 215
  16. 216
  17. 217

    Rhizomucor and Scedosporium Infection Post Hematopoietic Stem-Cell Transplant by Dânia Sofia Marques, Carlos Pinho Vaz, Rosa Branca, Fernando Campilho, Catarina Lamelas, Luis Pedro Afonso, Manuel Jacome, Eduardo Breda, Eurico Monteiro, António Campos Júnior

    Published 2011-01-01
    “…Hematopoietic stem-cell transplant recipients are at increased risk of developing invasive fungal infections. …”
    Get full text
    Article
  18. 218
  19. 219

    Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation by Yur-Ren Kuo, Chien-Chang Chen, Shigeru Goto, Pao-Yuan Lin, Fu-Chan Wei, Chao-Long Chen

    Published 2012-01-01
    “…Researchers have been eagerly seeking alternative methods that circumvent the long-term use of immunosuppressants. Mesenchymal stem cells (MSCs) show promise as an immunomodulatory therapeutic agent and are currently being tested in preclinical and clinical settings as therapies for autoimmune disorders or transplant rejection. …”
    Get full text
    Article
  20. 220

    Nanoplastics induces arrhythmia in human stem-cells derived cardiomyocytes by Shirley Pei Shan Chia, Jeremy Kah Sheng Pang, Winanto Winanto, Boon-Seng Soh

    Published 2025-01-01
    “…To enhance physiological relevance, this study investigated the impact of NPs on human cardiomyocytes (CMs) derived from human embryonic stem cells (hESCs). We observed significantly higher cellular uptake of 50 nm NPs compared to 500 nm particles, with dose-dependent accumulation over 3, 5, and 7 days of treatment. …”
    Get full text
    Article